BRITANNIA LIFE SCIENCES (L020) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.057x

Based on the latest financial reports, BRITANNIA LIFE SCIENCES (L020) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€989.01K ≈ $1.16 Million USD) by net assets (€17.23 Million ≈ $20.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is BRITANNIA LIFE SCIENCES's balance sheet to measure how much of total assets are equity-financed.

BRITANNIA LIFE SCIENCES - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how BRITANNIA LIFE SCIENCES's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BRITANNIA LIFE SCIENCES cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

BRITANNIA LIFE SCIENCES Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BRITANNIA LIFE SCIENCES ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ConnectM Technology Solutions, Inc.
NASDAQ:CNTM
0.098x
E79 Gold Mines Ltd
AU:E79
-0.156x
E-Pango SA
PA:ALAGO
0.796x
Bodegas Riojanas S.A.
MC:RIO
0.030x
TOP Ships Inc.
NYSE MKT:TOPS
0.081x
YGL Convergence Bhd
KLSE:0086
0.001x
ARK Resources Bhd
KLSE:7007
0.256x
Polar Power Inc
NASDAQ:POLA
-0.917x

Annual Cash Flow Conversion Efficiency for BRITANNIA LIFE SCIENCES (2022–2025)

The table below shows the annual cash flow conversion efficiency of BRITANNIA LIFE SCIENCES from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see BRITANNIA LIFE SCIENCES stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 €6.30 Million
≈ $7.37 Million
€-2.62 Million
≈ $-3.06 Million
-0.416x -232.59%
2024-03-31 €6.67 Million
≈ $7.80 Million
€2.09 Million
≈ $2.45 Million
0.314x +72.71%
2023-03-31 €11.06 Million
≈ $12.93 Million
€2.01 Million
≈ $2.35 Million
0.182x -64.44%
2022-03-31 €5.48 Million
≈ $6.41 Million
€2.80 Million
≈ $3.27 Million
0.511x --

About BRITANNIA LIFE SCIENCES

F:L020 Germany Biotechnology
Market Cap
$5.50 Million
€4.71 Million EUR
Market Cap Rank
#28398 Global
#2450 in Germany
Share Price
€0.03
Change (1 day)
+13.73%
52-Week Range
€0.03 - €0.07
All Time High
€0.15
About

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.